Commissariat a l'Energie Atomique et aux Energies Alternatives;Université Paris-Sud;Drugabilis
发明人:
Daniel Gillet,Jean-Christophe Cintrat,Julien Barbier,Alain Pruvost,Philippe Loiseau,Joël Vacus
申请号：
US16759475
公开号：
US20200281873A1
申请日:
2018.10.31
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention is in the field of therapeutic drugs to treat leishmaniasis. In particular, the invention concerns adamantane and bicyclic monoterpenoid derivatives for use in the treatment of leishmaniasis.
